Want to see TSE:CNO full AI Analyst Report?
California Nanotechnologies (CNO) Stock Statistics & Valuation Metrics
Total Valuation
California Nanotechnologies has a market cap or net worth of CAD 19.41M. The enterprise value is CAD 15.34M.
- Market Cap
- CAD 19.41M
- Enterprise Value
- CAD 15.34M
Share Statistics
California Nanotechnologies has 46,764,660 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 46,764,660
- Owned by Insiders
- 11.74%
- Owned by Institutions
- ―
Financial Efficiency
California Nanotechnologies’s return on equity (ROE) is -0.95 and return on invested capital (ROIC) is -61.74%.
- Return on Equity (ROE)
- -0.95
- Return on Assets (ROA)
- -0.49
- Return on Invested Capital (ROIC)
- -61.74%
- Return on Capital Employed (ROCE)
- -0.69
- Revenue Per Employee
- 141.73K
- Profits Per Employee
- -94.39K
- Employee Count
- 20
- Asset Turnover
- 0.73
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of California Nanotechnologies is -7.45. California Nanotechnologies’s PEG ratio is 0.06.
- PE Ratio
- -7.45
- PS Ratio
- 4.43
- PB Ratio
- 6.77
- Price to FCF
- -18.81
- Price to Operating Cash Flow
- -20.19
- PEG Ratio
- 0.06
Income Statement
In the last 12 months, California Nanotechnologies had revenue of 2.83M and earned -1.89M in profits. Earnings per share was -0.04.
- Revenue
- 2.83M
- Gross Profit
- -610.56K
- Operating Income
- -2.03M
- Pretax Income
- -1.88M
- Net Income
- -1.89M
- EBITDA
- -1.32M
- Earnings Per Share (EPS)
- -0.04
Cash Flow
In the last 12 months, operating cash flow was -715.38K and capital expenditures -29,562, giving a free cash flow of -744.94K billion.
- Operating Cash Flow
- -715.38K
- Free Cash Flow
- -744.94K
- Free Cash Flow per Share
- -0.02
Dividends & Yields
California Nanotechnologies pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -5.12%
- Earnings Yield
- -12.81%
Stock Price Statistics
- Beta
- 2.46
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.38
- 200-Day Moving Average
- 0.31
- Relative Strength Index (RSI)
- 58.31
- Average Volume (3m)
- 49.55K
Important Dates
California Nanotechnologies upcoming earnings date is Feb 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 27, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- ―
Financial Position
California Nanotechnologies as a current ratio of 0.93, with Debt / Equity ratio of 66.05%
- Current Ratio
- 0.93
- Quick Ratio
- 0.93
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- -0.83
- Interest Coverage Ratio
- -15.97
Taxes
In the past 12 months, California Nanotechnologies has paid 4,155 in taxes.
- Income Tax
- 4,155
- Effective Tax Rate
- -0.00
Enterprise Valuation
California Nanotechnologies EV to EBITDA ratio is -9.34, with an EV/FCF ratio of -20.62.
- EV to Sales
- 4.86
- EV to EBITDA
- -9.34
- EV to Free Cash Flow
- -20.62
- EV to Operating Cash Flow
- -21.47
Balance Sheet
California Nanotechnologies has CAD 152.46K in cash and marketable securities with CAD 957.14K in debt, giving a net cash position of -CAD 804.68K billion.
- Cash & Marketable Securities
- CAD 152.46K
- Total Debt
- CAD 957.14K
- Net Cash
- -CAD 804.68K
- Net Cash Per Share
- -CAD 0.02
- Tangible Book Value Per Share
- CAD 0.04
Margins
Gross margin is -1.88%, with operating margin of -66.31%, and net profit margin of -60.79%.
- Gross Margin
- -1.88%
- Operating Margin
- -66.31%
- Pretax Margin
- -61.57%
- Net Profit Margin
- -60.79%
- EBITDA Margin
- -52.02%
- EBIT Margin
- -73.66%
Analyst Forecast
The average price target for California Nanotechnologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -29.28%
- EPS Growth Forecast
- -95.12%
Scores
- Smart Score
- ―
- AI Score
- 45
